No Data
No Data
Lake Street Sticks to Its Buy Rating for Assertio Therapeutics (ASRT)
Assertio Holdings Analyst Ratings
H.C. Wainwright Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $4
Assertio Therapeutics: Strong Buy Rating Backed by Robust Margins and Strategic Revenue Growth
US Manufacturing Index Rises To 43, Highest Since 2020
Maxim Group Maintains Assertio(ASRT.US) With Buy Rating, Maintains Target Price $3
No Data
White_Shadow : yup
White_Shadow : seems like every executive just loaded up Boat load of shares....this is an excellent strong positive